Search

Aim: To determine factors associated with severe hospitalized Respiratory syncytial virus (RSV)-associated LRTI and to describe management in tertiary care center., Methods: Retrospective medical record review was conducted among children under 5 years old hospitalized with RSV-associated LRTI at King Chulalongkorn Memorial Hospital. Severe RSV-associated LRTI was defined as death, mechanical ventilator, or positive pressure ventilation use, prolonged hospitalization >7 days. Factors associated with severe RSV were analyzed using univariate and multivariate logistic regression., Results: From January 2011 to December 2016, 427 children were hospitalized. Median age was 10 months (IQR 4.2-23.0). One hundred seventy-four (41%) patients had severe RSV (11 deaths, 56 mechanical ventilators, 19 positive pressure ventilation, and 88 prolonged hospitalization). Factors associated with severe RSV were chronic lung disease (aOR 15.16 [4.26-53.91]), cirrhosis/biliary atresia (aOR 15.01 [3.21-70.32]), congenital heart disease (aOR 5.11 [1.97-13.23]), chemotherapy (aOR 4.7 [1.34-16.56]), and pre-term (aOR 2.03 [1.13-3.67]). Oxygen therapy was mainly low flow oxygen delivery. 88% of cases received bronchodilator. Parenteral antibiotics were prescribed in 37.9% of cases., Conclusions: Children with co-morbidities have higher risk of severe RSV-associated LRTI. More than two-third of patients received bronchodilator, of which was not recommended by American Academy of Pediatrics. The specific treatment and prevention for RSV are urgently needed., (© 2020 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.)

The 24-hour vancomycin area under the serum concentration-time curve (AUC 24 ) divided by the minimum inhibitory concentration (MIC) (AUC 24 /MIC) is more closely related to patient outcomes than serum trough concentrations (C trough ). Two-point simplified equations for calculating AUC based on serum peak concentrations (C peak ) and C trough , named equation A (EqA) and equation B (EqB), have recently been adopted into clinical use for adult pediatric patients. We aimed to find the agreement between predicted AUC 24 using the reference method (ref) relative to EqA and EqB and the correlation between C trough and AUC 24 . From June to December 2018, 43 pediatric patients with normal renal function, receiving 15 mg/kg of vancomycin intravenously every 6 hours, were enrolled. The pediatric patients' median age was 2.2 years (range 0.1-15.3). At steady state, vancomycin C peak and C trough were measured at 2 hours after infusion completion and within 30 minutes before the next dosing, respectively. AUC 24 was estimated using ref, EqA, and EqB. From Bland-Altman analysis, the 2 AUC 24 s estimated by ref and EqA showed less bias than those estimated by ref and EqB (bias 1.3 and -72.1 mg⋅h/L, respectively). C trough and AUC 24 using either ref or EqA were correlated more closely (r 2 = 0.94) than with EqB (r 2 = 0.86). Assuming a vancomycin MIC of 1 mg/L, an AUC 24 ≥400 mg⋅h/L was targeted. Regardless of the method used, AUC 24 ≥400 mg⋅h/L was never seen with C trough <8 mg/L but was always seen with C trough >10 mg/L. In conclusion, EqA based on the 2 measured serum concentrations was sufficiently accurate for AUC 24 estimation. C trough >10 mg/L correlated highly to AUC 24 ≥400 mg⋅h/L., (© 2019, The American College of Clinical Pharmacology.)